Table 3.
Time | AACCI | Survival %* | 95% CI | p |
---|---|---|---|---|
6 months | 2–5 | 97,40% | (92,1%; 99,1%) | 0,176 |
6–10 | 93,10% | (82,7%; 97,4%) | ||
12 months | 2–5 | 86,00% | (78,1%; 91,2%) | 0,579 |
6–10 | 82,80% | (70,3%; 90,3%) | ||
18 months | 2–5 | 78,90% | (70,3%; 85,4%) | 0,153 |
6–10 | 69,00% | (55,4%; 79,2%) | ||
24 months | 2–5 | 71,90% | (62,7%; 79,2%) | 0,123 |
6–10 | 60,30% | (46,6%;71,6%) | ||
36 months | 2–5 | 55,50% | (45,8%; 64,2%) | 0,021 |
6–10 | 36,90% | (24,5%; 49,3%) |
*The proportions of patients who survived at a given timepoint was derived from the Kaplan-Meier method with corresponding two-sided 95% CIs and p-values